3-169839992-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_024727.4(LRRC31):c.1649G>A(p.Gly550Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000447 in 1,609,554 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_024727.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LRRC31 | NM_024727.4 | c.1649G>A | p.Gly550Glu | missense_variant | 9/9 | ENST00000316428.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LRRC31 | ENST00000316428.10 | c.1649G>A | p.Gly550Glu | missense_variant | 9/9 | 1 | NM_024727.4 | P1 | |
LRRC31 | ENST00000523069.1 | c.*335G>A | 3_prime_UTR_variant | 9/9 | 1 | ||||
LRRC31 | ENST00000264676.9 | c.1481G>A | p.Gly494Glu | missense_variant | 8/8 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 151900Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000446 AC: 11AN: 246880Hom.: 0 AF XY: 0.0000448 AC XY: 6AN XY: 133860
GnomAD4 exome AF: 0.0000460 AC: 67AN: 1457654Hom.: 0 Cov.: 29 AF XY: 0.0000538 AC XY: 39AN XY: 724792
GnomAD4 genome AF: 0.0000329 AC: 5AN: 151900Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74180
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 16, 2021 | The c.1649G>A (p.G550E) alteration is located in exon 10 (coding exon 9) of the LRRC31 gene. This alteration results from a G to A substitution at nucleotide position 1649, causing the glycine (G) at amino acid position 550 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at